Related Experiment Video

Updated: Aug 4, 2026

Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Fatal sepsis in an AIDS patient during therapy for Pneumocystis carinii pneumonia

R J Piso1, M Rossi, T Oehler

  • 1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, CH-8091 Zurich, Switzerland. reinjan.piso@dim.usz.ch

Infection
|October 17, 2002
PubMed

Insights

A patient with newly diagnosed HIV and Pneumocystis pneumonia experienced acute deterioration and death despite treatment. This highlights the critical need for comprehensive screening for co-infections in immunocompromised individuals.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Critical Care Medicine

Background:

  • Presents a case of a patient with a new Human Immunodeficiency Virus (HIV) diagnosis.
  • The patient also had an initial diagnosis of Pneumocystis pneumonia, a common opportunistic infection in HIV patients.

Observation:

  • Despite initial improvement with high-dose trimethoprim/sulfamethoxazole (TMP/SMX) and prednisone, the patient rapidly declined.
  • The patient developed severe acidosis and died within four days of admission.
  • Post-mortem cultures revealed Cryptococcus neoformans in bronchoalveolar lavage and blood.

Findings:

  • The case illustrates a fatal outcome in an HIV-infected patient with Pneumocystis pneumonia.
  • Simultaneous opportunistic infections, such as Cryptococcus neoformans, can occur and complicate treatment.
  • Rapid clinical deterioration despite standard therapy underscores treatment challenges.

Implications:

  • Emphasizes the importance of a thorough diagnostic workup for multiple opportunistic infections in immunocompromised patients.
  • Suggests that co-infections may significantly impact patient prognosis and treatment response.
  • Highlights the need for vigilance and potentially broader empirical treatment strategies in managing HIV-related opportunistic infections.

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...